Breastfeeding and Breast Cancer: Managing Lactation in Survivors and Women with a New Diagnosis
Supporting breastfeeding is a global health priority, yet few clinical guidelines exist to guide surgical oncologists in managing lactation during or after breast cancer treatment.
The literature was reviewed to identify evidence-based strategies for managing lactation during multidisciplinary breast cancer treatment or among breast cancer survivors.
The majority of the evidence is from observational studies, with some higher levels of evidence, including systematic reviews and meta-analyses. Several significant gaps in knowledge remain.
This review serves as a comprehensive resource of evidence-based recommendations for managing lactation in breast cancer survivors and breastfeeding women with a new breast cancer diagnosis.
Dr. Mitchell acknowledges her patients for consenting to share their clinical and radiographic images.
Helen M. Johnson and Katrina B. Mitchell have nothing to disclose.
- 2.Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.CrossRefGoogle Scholar
- 5.Office of the Surgeon General (US); Centers for Disease Control and Prevention (US); Office on Women’s Health (US). The Surgeon General’s Call to Action to Support Breastfeeding. Rockville (MD): Office of the Surgeon General (US); 2011. Rates of Breastfeeding. https://www.ncbi.nlm.nih.gov/books/NBK52681/. Accessed 4 Jan 2019.
- 6.The Lancet. Breastfeeding: a missed opportunity for global health. Lancet. 2017;390(10094):532.Google Scholar
- 8.International Board of Lactation Consultant Examiners: History. https://iblce.org/about-iblce/history/. Accessed 11 June 2019.
- 9.Academy of Breastfeeding Medicine: about ABM. https://www.bfmed.org/about. Accessed 11 June 2019.
- 10.BFAR. Breastfeeding after breast and nipple surgeries. www.bfar.org. Accessed 13 Nov 2018.
- 25.The InfantRisk Center. Texas Tech University Health Sciences Center. 2019. https://www.infantrisk.com/. Accessed 4 Jan 2019.
- 42.Mattsson S, Johansson L, Leide Svegborn S, et al. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Annex D. Recommendations on breast-feeding interruptions. Ann ICRP. 2015;44(2 Suppl):319–21.Google Scholar
- 43.ACR Committee on Drugs and Contrast Media. American College of Radiology Manual on Contrast Media, Version 10.3. 11th edn. p 99–100. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf. Accessed 4 Jan 2019.
- 48.Drugs and Lactation Database (LactMed). U.S. National Library of Medicine, National Institute of Health, Health & Human Services. https://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm. Accessed 4 Jan 2019.
- 58.National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: genetic/familial high-risk assessment: breast and ovarian, Version 2.2019. https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed 19 Nov 2018.